The increasing use of prophylactic mastectomy in the prevention of breast cancer.
about
Risk-reducing medication for primary breast cancer: a network meta-analysisOncologic safety of conservative mastectomy in the therapeutic settingSocial Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.Lumbar herniation following extended autologous latissimus dorsi breast reconstruction.Equilibrium-phase high spatial resolution contrast-enhanced MR angiography at 1.5T in preoperative imaging for perforator flap breast reconstruction.Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysisTrends in Immediate Postmastectomy Breast Reconstruction in the United Kingdom.Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.Evaluating a Decision Aid for Improving Decision Making in Patients with Early-stage Breast Cancer.Knowledge, attitude and practice of prophylactic mastectomy among patients and relations attending a surgical outpatient clinic.Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits.Decision making for breast cancer prevention among women at elevated riskInnovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients.Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.Sentinel lymph node biopsy during prophylactic mastectomy: is there a role?Prophylactic mastectomy: who needs it, when and why.Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.Contralateral prophylactic mastectomy: a qualitative approach to exploring the decision making process.The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.Improvement in Existing Chest Wall Irregularities During Breast Reconstruction.Innovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients.Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.Direct-to-implant breast reconstruction: an analysis of 1612 cases from the ACS-NSQIP surgical outcomes database.Bilateral mastectomies: can a co-surgeon technique offer improvements over the single-surgeon method?Scoping clinicians' perspectives on pre-treatment multidisciplinary care for young women with breast cancer
P2860
Q24185817-A60EC517-249D-45FD-9008-22A01C87CFBFQ26768209-6FC4841D-EEC6-4589-927C-EC716FB7A218Q30489624-9B49E9A5-2BBA-474E-873A-4F93D339E1F3Q34747820-610EE5ED-F4E3-4CA9-8DE7-D906EB559CBFQ34979465-F5700639-0283-40DB-9CD4-8C60634A8458Q35192288-69E03CE7-E340-4998-ABF7-F216108CB4F8Q36131324-8C88CDF1-4953-4D64-A1D0-28AA5AD438BAQ36436637-6F3053E6-57E8-4784-B738-E4E0D3881AE3Q36470755-C0DA338F-E343-4441-AABE-209801DABA85Q36479848-815841FF-C073-4FB3-AF96-CCC0689AD658Q37151892-2633E7F5-9DF2-4B1A-A76C-50857787A6BBQ37661116-846C1030-6B97-41B7-A337-351C171B1FE9Q37720955-FF222051-4475-4086-B82A-3F37DDE7F6CCQ37730484-7964BA7B-EA2C-4D9D-B36A-F125E07ADFF3Q37955050-A1D427FC-4F48-417E-A818-9E31CB506170Q38188901-2414CB51-1296-4810-AD32-16082BCBAF42Q38223259-4933314D-4F8E-4F45-814D-35DE9770BC61Q38418228-A0BEA5D4-C518-4951-ABC8-1C2C4F1F9C8BQ39033804-17A0FAE3-8EE8-4FA6-BF2C-CB1ABD6C96E0Q39103033-5E9549D6-68CA-481E-96C6-643A3CF62716Q40312428-65B31D27-A499-44AB-9BF0-AD95D80BA7C3Q46044304-8D884D52-2CEC-4A54-B1E0-E5786698FA2AQ47311991-4F7D4061-FECB-4D34-964C-7B32578E59D4Q47735651-4C5F4CB0-E430-43F6-85FB-C2B7580EF2B3Q48518133-840AA37A-B2A8-4F5A-AB21-617BF20335C4Q50874663-B0B79D7F-1220-4112-A1BB-A76F8C6629A0Q51280306-BE9E9808-815B-41C7-9CB5-6C9748D6C754Q53588999-B30779BD-565C-4CBF-9C93-393D0D77DE40Q56334641-1B6463FB-D828-4A5F-9512-DB10F11733CEQ57817244-2FA1D2C1-8D1A-466E-8BA3-886E6799161F
P2860
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@en
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@nl
type
label
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@en
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@nl
prefLabel
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@en
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@nl
P2093
P1476
The increasing use of prophylactic mastectomy in the prevention of breast cancer.
@en
P2093
Andrea Abbott
Natasha Rueth
Todd M Tuttle
P2860
P2888
P356
10.1007/S11912-009-0070-Y
P577
2010-01-01T00:00:00Z